Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

It is time for universal HPV vaccination.

Prue G, Baker P, Graham D, Nutting C, Greenhouse P, Lawler M.

Lancet. 2018 Sep 15;392(10151):913-914. doi: 10.1016/S0140-6736(18)31821-X. No abstract available.

PMID:
30238882
2.

Multilevel Analysis of Child and Adolescent Subjective Well-Being Across 14 Countries: Child- and Country-Level Predictors.

Newland LA, Giger JT, Lawler MJ, Roh S, Brockevelt BL, Schweinle A.

Child Dev. 2018 Sep 1. doi: 10.1111/cdev.13134. [Epub ahead of print]

PMID:
30171770
3.

Rapid growth of organic aerosol nanoparticles over a wide tropospheric temperature range.

Stolzenburg D, Fischer L, Vogel AL, Heinritzi M, Schervish M, Simon M, Wagner AC, Dada L, Ahonen LR, Amorim A, Baccarini A, Bauer PS, Baumgartner B, Bergen A, Bianchi F, Breitenlechner M, Brilke S, Buenrostro Mazon S, Chen D, Dias A, Draper DC, Duplissy J, El Haddad I, Finkenzeller H, Frege C, Fuchs C, Garmash O, Gordon H, He X, Helm J, Hofbauer V, Hoyle CR, Kim C, Kirkby J, Kontkanen J, Kürten A, Lampilahti J, Lawler M, Lehtipalo K, Leiminger M, Mai H, Mathot S, Mentler B, Molteni U, Nie W, Nieminen T, Nowak JB, Ojdanic A, Onnela A, Passananti M, Petäjä T, Quéléver LLJ, Rissanen MP, Sarnela N, Schallhart S, Tauber C, Tomé A, Wagner R, Wang M, Weitz L, Wimmer D, Xiao M, Yan C, Ye P, Zha Q, Baltensperger U, Curtius J, Dommen J, Flagan RC, Kulmala M, Smith JN, Worsnop DR, Hansel A, Donahue NM, Winkler PM.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9122-9127. doi: 10.1073/pnas.1807604115. Epub 2018 Aug 28.

4.

Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer.

Montroni I, Ugolini G, Saur NM, Spinelli A, Rostoft S, Millan M, Wolthuis A, Daniels IR, Hompes R, Penna M, Fürst A, Papamichael D, Desai AM, Cascinu S, Gèrard JP, Myint AS, Lemmens VEPP, Berho M, Lawler M, De Liguori Carino N, Potenti F, Nanni O, Altini M, Beets G, Rutten H, Winchester D, Wexner SD, Audisio RA.

Eur J Surg Oncol. 2018 Aug 15. pii: S0748-7983(18)31272-1. doi: 10.1016/j.ejso.2018.08.003. [Epub ahead of print] Review.

PMID:
30150158
5.

Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition.

McCorry AMB, Loughrey MB, Longley DB, Lawler M, Dunne PD.

J Pathol. 2018 Aug 13. doi: 10.1002/path.5155. [Epub ahead of print]

PMID:
30105762
6.

A roadmap for restoring trust in Big Data.

Lawler M, Morris AD, Sullivan R, Birney E, Middleton A, Makaroff L, Knoppers BM, Horgan D, Eggermont A.

Lancet Oncol. 2018 Aug;19(8):1014-1015. doi: 10.1016/S1470-2045(18)30425-X. No abstract available.

PMID:
30102210
7.

Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy.

Allen WL, Dunne PD, McDade S, Scanlon E, Loughrey M, Coleman H, McCann C, McLaughlin K, Nemeth Z, Syed N, Jithesh P, Arthur K, Wilson R, Coyle V, McArt D, Murray GI, Samuel L, Nuciforo P, Jimenez J, Argiles G, Dienstmann R, Tabernero J, Messerini L, Nobili S, Mini E, Sheahan K, Ryan E, Johnston PG, Van Schaeybroeck S, Lawler M, Longley DB.

JCO Precis Oncol. 2018 Jun 13;2018. doi: 10.1200/PO.17.00241.

8.

Mapping the European cancer research landscape: An evidence base for national and Pan-European research and funding.

Begum M, Lewison G, Lawler M, Sullivan R.

Eur J Cancer. 2018 Sep;100:75-84. doi: 10.1016/j.ejca.2018.04.017. Epub 2018 Jul 4.

9.

Title V Maternal and Child Health Services Block Grant Priority Needs and Linked Performance Measures: Current Patterns and Trends (2000-2015).

Kandasamy V, Hirai AH, Kogan MD, Lawler M, Volpe E.

Matern Child Health J. 2018 Jul 11. doi: 10.1007/s10995-018-2568-0. [Epub ahead of print]

PMID:
29995296
10.

Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer.

Dunne PD, Coleman HG, Bankhead P, Alderdice M, Gray RT, McQuaid S, Bingham V, Loughrey MB, James JA, McCorry AMB, Gilmore A, Holohan C, Klingbiel D, Tejpar S, Johnston PG, McArt DG, Di Nicolantonio F, Longley DB, Lawler M.

Oncotarget. 2018 Feb 13;9(17):13834-13847. doi: 10.18632/oncotarget.24481. eCollection 2018 Mar 2.

11.

Delivering modern, high-quality, affordable pathology and laboratory medicine to low-income and middle-income countries: a call to action.

Horton S, Sullivan R, Flanigan J, Fleming KA, Kuti MA, Looi LM, Pai SA, Lawler M.

Lancet. 2018 May 12;391(10133):1953-1964. doi: 10.1016/S0140-6736(18)30460-4. Epub 2018 Mar 15. Review.

PMID:
29550030
12.

Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions.

Sayed S, Cherniak W, Lawler M, Tan SY, El Sadr W, Wolf N, Silkensen S, Brand N, Looi LM, Pai SA, Wilson ML, Milner D, Flanigan J, Fleming KA.

Lancet. 2018 May 12;391(10133):1939-1952. doi: 10.1016/S0140-6736(18)30459-8. Epub 2018 Mar 15. Review.

PMID:
29550027
13.

Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy.

Kirk J, Shah N, Noll B, Stevens CB, Lawler M, Mougeot FB, Mougeot JC.

Support Care Cancer. 2018 Aug;26(8):2695-2705. doi: 10.1007/s00520-018-4096-2. Epub 2018 Feb 23.

PMID:
29476419
14.

Mapping the cancer patient information landscape: A comparative analysis of patient groups across Europe and North America.

Lawler M, Prue G, Banks I, Law K, Selby P, McVie G, Sullivan R.

Eur J Cancer. 2018 Mar;92:88-95. doi: 10.1016/j.ejca.2018.01.074. Epub 2018 Feb 9.

PMID:
29428868
15.

Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.

Alderdice M, Richman SD, Gollins S, Stewart JP, Hurt C, Adams R, McCorry AM, Roddy AC, Vimalachandran D, Isella C, Medico E, Maughan T, McArt DG, Lawler M, Dunne PD.

J Pathol. 2018 May;245(1):19-28. doi: 10.1002/path.5051. Epub 2018 Mar 25.

16.

Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges.

Bradley CA, Salto-Tellez M, Laurent-Puig P, Bardelli A, Rolfo C, Tabernero J, Khawaja HA, Lawler M, Johnston PG, Van Schaeybroeck S; MErCuRIC consortium.

Nat Rev Clin Oncol. 2018 Jan 23;15(3):150. doi: 10.1038/nrclinonc.2018.13. [Epub ahead of print]

PMID:
29358775
17.

Effect of Eukarion-134 on Akt-mTOR signalling in the rat soleus during 7 days of mechanical unloading.

Kuczmarski JM, Hord JM, Lee Y, Guzzoni V, Rodriguez D, Lawler MS, Garcia-Villatoro EL, Holly D, Ryan P, Falcon K, Garcia M, Janini Gomes M, Fluckey JD, Lawler JM.

Exp Physiol. 2018 Apr 1;103(4):545-558. doi: 10.1113/EP086649. Epub 2018 Feb 28.

PMID:
29315934
18.

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.

Lawler M, Alsina D, Adams RA, Anderson AS, Brown G, Fearnhead NS, Fenwick SW, Halloran SP, Hochhauser D, Hull MA, Koelzer VH, McNair AGK, Monahan KJ, Näthke I, Norton C, Novelli MR, Steele RJC, Thomas AL, Wilde LM, Wilson RH, Tomlinson I; Bowel Cancer UK Critical Research Gaps in Colorectal Cancer Initiative.

Gut. 2018 Jan;67(1):179-193. doi: 10.1136/gutjnl-2017-315333. Review.

19.

Comparison of the Spectral-Temporally Modulated Ripple Test With the Arizona Biomedical Institute Sentence Test in Cochlear Implant Users.

Lawler M, Yu J, Aronoff JM.

Ear Hear. 2017 Nov/Dec;38(6):760-766. doi: 10.1097/AUD.0000000000000496.

PMID:
28957975
20.

The European Cancer Patient's Bill of Rights, update and implementation 2016.

Højgaard L, Löwenberg B, Selby P, Lawler M, Banks I, Law K, Albreht T, Armand JP, Barbacid M, Barzach M, Bergh J, Cameron D, Conte P, de Braud F, de Gramont A, De Lorenzo F, Diehl V, Diler S, Erdem S, Geissler J, Gore-Booth J, Henning G, Horgan D, Jassem J, Johnson P, Kaasa S, Kapitein P, Karjalainen S, Kelly J, Kienesberger A, La Vecchia C, Lacombe D, Lindahl T, Luzzatto L, Malby R, Mastris K, Meunier F, Murphy M, Naredi P, Nurse P, Oliver K, Pearce J, Pelouchov J, Piccart M, Pinedo B, Spurrier-Bernard G, Sullivan R, Tabernero J, Van de Velde C, van Herk B, Vedsted P, Waldmann A, Weller D, Wilking N, Wilson R, Yared W, Zielinski C, Zur Hausen H, Le Chevalier T, Johnston P.

ESMO Open. 2017 Jan 6;1(6):e000127. doi: 10.1136/esmoopen-2016-000127. eCollection 2016. Review.

21.

Variations in adolescents' motivational characteristics across gender and physical activity patterns: A latent class analysis approach.

Lawler M, Heary C, Nixon E.

BMC Public Health. 2017 Aug 17;17(1):661. doi: 10.1186/s12889-017-4677-x.

22.

Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.

Alderdice M, Dunne PD, Cole AJ, O'Reilly PG, McArt DG, Bingham V, Fuchs MA, McQuaid S, Loughrey MB, Murray GI, Samuel LM, Lawler M, Wilson RH, Salto-Tellez M, Coyle VM.

Mod Pathol. 2017 Sep;30(9):1287-1298. doi: 10.1038/modpathol.2017.47. Epub 2017 Jun 16.

23.

Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.

Alvi MA, Loughrey MB, Dunne P, McQuaid S, Turkington R, Fuchs MA, McGready C, Bingham V, Pang B, Moore W, Maxwell P, Lawler M, James JA, Murray GI, Wilson RH, Salto-Tellez M.

Br J Cancer. 2017 Jul 11;117(2):203-209. doi: 10.1038/bjc.2017.168. Epub 2017 Jun 8.

24.

Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification.

Dunne PD, Alderdice M, O'Reilly PG, Roddy AC, McCorry AMB, Richman S, Maughan T, McDade SS, Johnston PG, Longley DB, Kay E, McArt DG, Lawler M.

Nat Commun. 2017 May 31;8:15657. doi: 10.1038/ncomms15657.

25.

Standardising RNA profiling based biomarker application in cancer-The need for robust control of technical variables.

Stewart JP, Richman S, Maughan T, Lawler M, Dunne PD, Salto-Tellez M.

Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):258-272. doi: 10.1016/j.bbcan.2017.05.005. Epub 2017 May 23. Review.

26.

Sharing Clinical and Genomic Data on Cancer - The Need for Global Solutions.

Clinical Cancer Genome Task Team of the Global Alliance for Genomics and Health, Lawler M, Haussler D, Siu LL, Haendel MA, McMurry JA, Knoppers BM, Chanock SJ, Calvo F, The BT, Walia G, Banks I, Yu PP, Staudt LM, Sawyers CL.

N Engl J Med. 2017 May 25;376(21):2006-2009. doi: 10.1056/NEJMp1612254. No abstract available.

27.

From Rosalind Franklin to Barack Obama: Data Sharing Challenges and Solutions in Genomics and Personalised Medicine.

Lawler M, Maughan T.

New Bioeth. 2017 Apr;23(1):64-73. doi: 10.1080/20502877.2017.1314883.

28.

Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape.

Vis DJ, Lewin J, Liao RG, Mao M, Andre F, Ward RL, Calvo F, Teh BT, Camargo AA, Knoppers BM, Sawyers CL, Wessels LFA, Lawler M, Siu LL, Voest E; Clinical Working Group of the Global Alliance for Genomics and Health.

Ann Oncol. 2017 May 1;28(5):1145-1151. doi: 10.1093/annonc/mdx037.

29.

Intratumoural Epigenetic Heterogeneity in Early Invasive Colorectal Cancer: A Prognostic Imprint?

Dunne PD, Lawler M.

Gastroenterology. 2017 May;152(6):1622-1623. doi: 10.1053/j.gastro.2016.09.071. Epub 2017 Apr 3. No abstract available.

PMID:
28384444
30.

Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges.

Bradley CA, Salto-Tellez M, Laurent-Puig P, Bardelli A, Rolfo C, Tabernero J, Khawaja HA, Lawler M, Johnston PG, Van Schaeybroeck S; MErCuRIC consortium.

Nat Rev Clin Oncol. 2017 Sep;14(9):562-576. doi: 10.1038/nrclinonc.2017.40. Epub 2017 Apr 4. Review. Erratum in: Nat Rev Clin Oncol. 2018 Jan 23;:.

PMID:
28374784
31.

The potential consequences for cancer care and cancer research of Brexit.

Selby P, Lawler M, Baird R, Banks I, Johnston P, Nurse P.

Ecancermedicalscience. 2017 Feb 24;11:ed63. doi: 10.3332/ecancer.2017.ed63. eCollection 2017.

32.

Global atmospheric particle formation from CERN CLOUD measurements.

Dunne EM, Gordon H, Kürten A, Almeida J, Duplissy J, Williamson C, Ortega IK, Pringle KJ, Adamov A, Baltensperger U, Barmet P, Benduhn F, Bianchi F, Breitenlechner M, Clarke A, Curtius J, Dommen J, Donahue NM, Ehrhart S, Flagan RC, Franchin A, Guida R, Hakala J, Hansel A, Heinritzi M, Jokinen T, Kangasluoma J, Kirkby J, Kulmala M, Kupc A, Lawler MJ, Lehtipalo K, Makhmutov V, Mann G, Mathot S, Merikanto J, Miettinen P, Nenes A, Onnela A, Rap A, Reddington CL, Riccobono F, Richards NA, Rissanen MP, Rondo L, Sarnela N, Schobesberger S, Sengupta K, Simon M, Sipilä M, Smith JN, Stozkhov Y, Tomé A, Tröstl J, Wagner PE, Wimmer D, Winkler PM, Worsnop DR, Carslaw KS.

Science. 2016 Dec 2;354(6316):1119-1124. Epub 2016 Oct 27.

33.

Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer.

Bradley CA, Dunne PD, Bingham V, McQuaid S, Khawaja H, Craig S, James J, Moore WL, McArt DG, Lawler M, Dasgupta S, Johnston PG, Van Schaeybroeck S.

Oncotarget. 2016 Nov 29;7(48):78932-78945. doi: 10.18632/oncotarget.12933.

34.

Commensurate 4a0-period charge density modulations throughout the Bi2Sr2CaCu2O8+x pseudogap regime.

Mesaros A, Fujita K, Edkins SD, Hamidian MH, Eisaki H, Uchida SI, Davis JCS, Lawler MJ, Kim EA.

Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12661-12666. doi: 10.1073/pnas.1614247113. Epub 2016 Oct 20.

35.

Poster 326 Paraneoplastic Ovarian Teratoma Anti-NMDA Receptor Encephalitis: A Case Report.

Kremm LA, Armstrong Q, Lawler MH.

PM R. 2016 Sep;8(9S):S267. doi: 10.1016/j.pmrj.2016.07.496. Epub 2016 Sep 24. No abstract available.

PMID:
27673080
36.

Poster 69 Regaining Independence in Adult Onset Still's Disease: A Case Report.

Minori JJ, Wieseltier EH, Benjamin C, Lawler MH.

PM R. 2016 Sep;8(9S):S184. doi: 10.1016/j.pmrj.2016.07.112. Epub 2016 Sep 24. No abstract available.

PMID:
27672838
37.

A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer.

Salvucci M, Würstle ML, Morgan C, Curry S, Cremona M, Lindner AU, Bacon O, Resler AJ, Murphy ÁC, O'Byrne R, Flanagan L, Dasgupta S, Rice N, Pilati C, Zink E, Schöller LM, Toomey S, Lawler M, Johnston PG, Wilson R, Camilleri-Broët S, Salto-Tellez M, McNamara DA, Kay EW, Laurent-Puig P, Van Schaeybroeck S, Hennessy BT, Longley DB, Rehm M, Prehn JH.

Clin Cancer Res. 2017 Mar 1;23(5):1200-1212. doi: 10.1158/1078-0432.CCR-16-1084. Epub 2016 Sep 20.

38.

Human papillomavirus (HPV): making the case for 'Immunisation for All'.

Prue G, Lawler M, Baker P, Warnakulasuriya S.

Oral Dis. 2017 Sep;23(6):726-730. doi: 10.1111/odi.12562. Epub 2016 Aug 29. Review.

PMID:
27492979
39.

The EU: what's best for UK cancer research and patients?

Selby P, Lawler M, Banks I, Johnston P, Nurse P.

Lancet Oncol. 2016 May;17(5):556-7. doi: 10.1016/S1470-2045(16)30063-8. Epub 2016 Apr 27. No abstract available.

PMID:
27301027
40.

Shooting for the Moon or Flying Too Near the Sun? Crossing the Value Rubicon in Precision Cancer Care.

Lawler M, French D, Henderson R, Aggarwal A, Sullivan R.

Public Health Genomics. 2016;19(3):132-6. doi: 10.1159/000446530. Epub 2016 Jun 1.

PMID:
27238737
41.

Enabling Equal Access to Molecular Diagnostics: What Are the Implications for Policy and Health Technology Assessment?

Plun-Favreau J, Immonen-Charalambous K, Steuten L, Strootker A, Rouzier R, Horgan D, Lawler M.

Public Health Genomics. 2016;19(3):144-52. doi: 10.1159/000446532. Epub 2016 Jun 1.

42.

The role of low-volatility organic compounds in initial particle growth in the atmosphere.

Tröstl J, Chuang WK, Gordon H, Heinritzi M, Yan C, Molteni U, Ahlm L, Frege C, Bianchi F, Wagner R, Simon M, Lehtipalo K, Williamson C, Craven JS, Duplissy J, Adamov A, Almeida J, Bernhammer AK, Breitenlechner M, Brilke S, Dias A, Ehrhart S, Flagan RC, Franchin A, Fuchs C, Guida R, Gysel M, Hansel A, Hoyle CR, Jokinen T, Junninen H, Kangasluoma J, Keskinen H, Kim J, Krapf M, Kürten A, Laaksonen A, Lawler M, Leiminger M, Mathot S, Möhler O, Nieminen T, Onnela A, Petäjä T, Piel FM, Miettinen P, Rissanen MP, Rondo L, Sarnela N, Schobesberger S, Sengupta K, Sipilä M, Smith JN, Steiner G, Tomè A, Virtanen A, Wagner AC, Weingartner E, Wimmer D, Winkler PM, Ye P, Carslaw KS, Curtius J, Dommen J, Kirkby J, Kulmala M, Riipinen I, Worsnop DR, Donahue NM, Baltensperger U.

Nature. 2016 May 26;533(7604):527-31. doi: 10.1038/nature18271.

43.

The effect of acid-base clustering and ions on the growth of atmospheric nano-particles.

Lehtipalo K, Rondo L, Kontkanen J, Schobesberger S, Jokinen T, Sarnela N, Kürten A, Ehrhart S, Franchin A, Nieminen T, Riccobono F, Sipilä M, Yli-Juuti T, Duplissy J, Adamov A, Ahlm L, Almeida J, Amorim A, Bianchi F, Breitenlechner M, Dommen J, Downard AJ, Dunne EM, Flagan RC, Guida R, Hakala J, Hansel A, Jud W, Kangasluoma J, Kerminen VM, Keskinen H, Kim J, Kirkby J, Kupc A, Kupiainen-Määttä O, Laaksonen A, Lawler MJ, Leiminger M, Mathot S, Olenius T, Ortega IK, Onnela A, Petäjä T, Praplan A, Rissanen MP, Ruuskanen T, Santos FD, Schallhart S, Schnitzhofer R, Simon M, Smith JN, Tröstl J, Tsagkogeorgas G, Tomé A, Vaattovaara P, Vehkamäki H, Vrtala AE, Wagner PE, Williamson C, Wimmer D, Winkler PM, Virtanen A, Donahue NM, Carslaw KS, Baltensperger U, Riipinen I, Curtius J, Worsnop DR, Kulmala M.

Nat Commun. 2016 May 20;7:11594. doi: 10.1038/ncomms11594.

44.

Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy.

Dunne PD, McArt DG, O'Reilly PG, Coleman HG, Allen WL, Loughrey M, Van Schaeybroeck S, McDade S, Salto-Tellez M, Longley DB, Lawler M, Johnston PG.

Cancer Immunol Res. 2016 Jul;4(7):582-91. doi: 10.1158/2326-6066.CIR-15-0302. Epub 2016 May 13.

45.

Stratified analysis reveals chemokine-like factor (CKLF) as a potential prognostic marker in the MSI-immune consensus molecular subtype CMS1 of colorectal cancer.

Dunne PD, O'Reilly PG, Coleman HG, Gray RT, Longley DB, Johnston PG, Salto-Tellez M, Lawler M, McArt DG.

Oncotarget. 2016 Jun 14;7(24):36632-36644. doi: 10.18632/oncotarget.9126.

46.

Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer.

Dunne PD, McArt DG, Bradley CA, O'Reilly PG, Barrett HL, Cummins R, O'Grady T, Arthur K, Loughrey MB, Allen WL, McDade SS, Waugh DJ, Hamilton PW, Longley DB, Kay EW, Johnston PG, Lawler M, Salto-Tellez M, Van Schaeybroeck S.

Clin Cancer Res. 2016 Aug 15;22(16):4095-104. doi: 10.1158/1078-0432.CCR-16-0032. Epub 2016 May 5.

47.

Facilitating a culture of responsible and effective sharing of cancer genome data.

Siu LL, Lawler M, Haussler D, Knoppers BM, Lewin J, Vis DJ, Liao RG, Andre F, Banks I, Barrett JC, Caldas C, Camargo AA, Fitzgerald RC, Mao M, Mattison JE, Pao W, Sellers WR, Sullivan P, Teh BT, Ward RL, ZenKlusen JC, Sawyers CL, Voest EE.

Nat Med. 2016 May 5;22(5):464-71. doi: 10.1038/nm.4089.

48.

Detection of a Cooper-pair density wave in Bi2Sr2CaCu2O8+x.

Hamidian MH, Edkins SD, Joo SH, Kostin A, Eisaki H, Uchida S, Lawler MJ, Kim EA, Mackenzie AP, Fujita K, Lee J, Davis JC.

Nature. 2016 Apr 21;532(7599):343-7. doi: 10.1038/nature17411. Epub 2016 Apr 13.

PMID:
27074504
49.

A History of Childhood Maltreatment and Intimate Partner Violence Victimization Among Native American Adults.

Kong J, Roh S, Easton SD, Lee YS, Lawler MJ.

J Interpers Violence. 2018 Sep;33(18):2826-2848. doi: 10.1177/0886260516632353. Epub 2016 Feb 24.

PMID:
26912487
50.

Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program.

Lawler M, Gavin A, Salto-Tellez M, Kennedy RD, Van Schaeybroeck S, Wilson RH, Harkin DP, Grayson M, Boyd RE, Hamilton PW, McArt DG, James J, Robson T, Ladner RD, Prise KM, O'Sullivan JM, Harrison T, Murray L, Johnston PG, Waugh DJ.

Cancer. 2016 Mar 1;122(5):664-73. doi: 10.1002/cncr.29814. Epub 2015 Dec 22. No abstract available.

Supplemental Content

Loading ...
Support Center